Publication details

Pergolid mesylát (Permax) jako adjuvantní léčba Parkinsonovy nemoci - prospektivní, otevřená, šstiměsíční studie

Title in English Pergolide Mesylate (Permax) as Adjuvant Treatment of Parkinson's Disease - Prospective, Open 6-month Study
Authors

BAREŠ Martin REKTOR Ivan KAŇOVSKÝ Petr; HORTOVÁ Hana STREITOVÁ Hana KUBOVÁ Dagmar REKTOROVÁ Irena

Year of publication 2001
Type Article in Periodical
Magazine / Source Česká a slovenská neurologie a neurochirurgie
MU Faculty or unit

Faculty of Medicine

Citation
Field Neurology, neurosurgery, neurosciences
Keywords pergolide; add-on therapy; Parkinson disease
Description Twenty-four patients with idiopathic Parkinson's disease were followed up perspectively during a 6-month period to test the incidence of undesirable effects of the preparation pergolide mesylate (Permax).
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info